ClinicalTrials.Veeva

Menu

Clopidogrel Response in Acute Ischemic Stroke (Bo-CRISP)

R

Ruhr University of Bochum

Status

Completed

Conditions

Ischemic Stroke

Study type

Observational

Funder types

Other

Identifiers

NCT01846572
RUB-Neuro-2013-clopi

Details and patient eligibility

About

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Enrollment

159 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute ischemic stroke
  • admittance to stroke unit
  • clopidogrel medication

Exclusion criteria

  • no consent
  • prior bleeding disorders
  • severe liver disorders
  • current gastrointestinal disorders
  • congestive heart failure
  • life-threatening malignancies

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems